Phelcom Technologies participated in the 21st National Free Diabetes Prevention Campaign, sponsored by the National Association of Diabetes Care (Anad), from November 7 to 14 in São Paulo, in partnership with the Instituto da Visão (Ipepo), Federal University of São Paulo (Unifesp) and the German multinational Bayer. The event is related to the World Diabetes Day, celebrated on November 14.

At the time, the Brazilian startup examined about 500 patients with the portable fundus camera Eyer, an innovative product with high technology that will be launched soon by the company. “One of the chronic complications of diabetes is diabetic retinopathy, an early-stage asymptomatic disease that can cause severe visual impairment or even blindness when not diagnosed,” said Phelcom’s co-founder and CTO, Diego Lencione, who represented the company in this event.

More than 18 million people have diabetes in Brazil. The number may be higher because many cases have not yet been identified. “Today, almost 85% of Brazilian cities do not have access to ophthalmologists and ophthalmological devices that help diagnose the disease and its complications. Our objective with this portable device is to enable the care of communities that have limited access to this type of examination,” says Lencione.

Exams performed by the Phelcom portable retinal camera facilitated the diagnosis of retinal lesions and early referral for proper treatment of many patients during the task force.

Eyer

Eyer is a portable retinal camera developed by Phelcom Technologies that aims to help combat severe visual impairment and blindness, which affect more than 250 million people worldwide. Currently, 75% of cases occur due to lack of prevention, early diagnosis and correct treatment.